The role of microRNAs in depression

Area of Science:

• Neuroscience
• Molecular Biology
• Psychiatry

Background:

• Major depressive disorder (MDD) is a prevalent global psychiatric condition, posing significant challenges in diagnosis and treatment due to complex pathogenesis.
• MicroRNAs (miRNAs), small non-coding RNAs regulating gene expression, are abundant in brain tissues and are increasingly investigated for their role in neurological disorders.
• Understanding miRNA involvement is crucial for advancing depression research beyond its current exploratory phase.

Purpose of the Study:

• To summarize recent advancements in the understanding of microRNA involvement in the pathophysiology of major depressive disorder.
• To explore the potential of microRNAs as biomarkers for MDD diagnosis and as targets for novel therapeutic strategies.
• To review the regulatory roles of microRNAs in key pathways implicated in depression.

Main Methods:

• Literature review of recent scientific publications on microRNAs and depression.
• Analysis of studies investigating miRNA expression patterns in relation to MDD.
• Synthesis of research on miRNA-mediated regulation of monoaminergic systems, neuroplasticity, HPA axis, and inflammation.

Main Results:

• MicroRNAs are confirmed to play a significant regulatory role in the biological mechanisms underlying depression.
• Dysregulation of specific microRNAs is associated with alterations in monoamine levels, neuroplasticity, neurogenesis, HPA axis activity, and inflammatory responses.
• Evidence suggests microRNAs are involved in the complex pathogenesis of major depressive disorder.

Conclusions:

• MicroRNAs represent a promising avenue for developing innovative diagnostic tools for MDD.
• Targeting microRNAs could lead to the development of novel antidepressant medications and therapeutic interventions.
• Further research into microRNA function is essential for a comprehensive understanding and effective treatment of depression.